![](/img/cover-not-exists.png)
(761): A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects
L. Webster, J. Jansen, J. Peppin, B. Lasko, J. Snidow, A. Pierce, E. Mortensen, C. Kleoudis, E. CarterVolume:
7
Year:
2006
Language:
english
DOI:
10.1016/j.jpain.2006.01.163
File:
PDF, 46 KB
english, 2006